These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 7811617)
1. Drugs used to lower high lipid levels. Hopkins SJ Nurs Stand; 1994 Nov 2-8; 9(6):27-9. PubMed ID: 7811617 [TBL] [Abstract][Full Text] [Related]
2. Current and future therapeutic approaches to hyperlipidemia. Farmer JA; Gotto AM Adv Pharmacol; 1996; 35():79-114. PubMed ID: 8920205 [No Abstract] [Full Text] [Related]
3. Lipid-lowering drugs in lupus: an unexplored therapeutic intervention. Wierzbicki AS Lupus; 2001; 10(3):233-6. PubMed ID: 11315359 [TBL] [Abstract][Full Text] [Related]
4. The clofibrate saga: a retrospective commentary. Oliver M Br J Clin Pharmacol; 2012 Dec; 74(6):907-10. PubMed ID: 22486628 [No Abstract] [Full Text] [Related]
5. Utility of currently available modes of therapy in reaching lipid goals. Spratt KA; Denke MA J Am Osteopath Assoc; 2004 Sep; 104(9 Suppl 7):S14-6. PubMed ID: 15467019 [TBL] [Abstract][Full Text] [Related]
6. [Overviews of fibrate]. Tada N Nihon Rinsho; 2001 Mar; 59 Suppl 3():609-17. PubMed ID: 11347141 [No Abstract] [Full Text] [Related]
8. Role of fibrates in the management of hypertriglyceridemia. Rader DJ; Haffner SM Am J Cardiol; 1999 May; 83(9B):30F-35F. PubMed ID: 10357573 [TBL] [Abstract][Full Text] [Related]
9. [HDL, or non-HDL: that is the question. Possibilities of pharmacological treatment in residual dyslipidaemia]. Bajnok L Orv Hetil; 2014 Jan; 155(2):62-8. PubMed ID: 24389322 [TBL] [Abstract][Full Text] [Related]
10. Drugs for hypertriglyceridemia. Med Lett Drugs Ther; 2013 Mar; 55(1411):17-9. PubMed ID: 23467119 [No Abstract] [Full Text] [Related]
11. Choice of cholesterol-lowering drugs. Med Lett Drugs Ther; 1991 Jan; 33(835):1-4. PubMed ID: 1984601 [No Abstract] [Full Text] [Related]
12. Effect of combination lipid-modifying therapy on the triglyceride lowering effect of fish oil. Aligeti VR; Gandhi M; Braden R; Rezk A; Elam MB Am J Med Sci; 2007 Mar; 333(3):168-72. PubMed ID: 17496735 [TBL] [Abstract][Full Text] [Related]
13. Combination therapy for dyslipidemia: safety and regulatory considerations. Davidson MH Am J Cardiol; 2002 Nov; 90(10B):50K-60K. PubMed ID: 12467940 [TBL] [Abstract][Full Text] [Related]
14. Choice of cholesterol-lowering drugs. Med Lett Drugs Ther; 1993 Mar; 35(891):19-22. PubMed ID: 8433674 [No Abstract] [Full Text] [Related]
15. Advances in lipid-lowering therapy in atherosclerosis. Davignon J Adv Exp Med Biol; 2001; 498():49-58. PubMed ID: 11900401 [TBL] [Abstract][Full Text] [Related]
16. Colestipol hydrochloride, a new hypolipidemic drug: a two-year study. Cooper EE; Michel AM South Med J; 1975 Mar; 68(3):303-9. PubMed ID: 1091001 [TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of combined statin-fenofibrates therapy compared with monotherapy in patients with mixed hyperlipidemia and high risk of coronary heart disease]. Kłosiewicz-Latoszek L; Respondek W; Białobrzeska-Paluszkiewicz J; Grzybowska B; Jakóbisiak-Ostasz B; Stolarska I Pol Merkur Lekarski; 2003 Jul; 15(85):42-6. PubMed ID: 14593958 [TBL] [Abstract][Full Text] [Related]
18. Economic implications of lipid-lowering trials: current considerations in selecting a statin. Farmer JA Am J Cardiol; 1998 Sep; 82(6A):26M-31M. PubMed ID: 9766345 [TBL] [Abstract][Full Text] [Related]
19. Hyperlipoproteinemias: part IV. Drug regimens. Vogt HB S D J Med; 1991 May; 44(5):117-20. PubMed ID: 1871582 [TBL] [Abstract][Full Text] [Related]